Heenan M, Kavanagh K, Redmond A, Maher M, Dolan E, O'Neill P, Moriarty M, Clynes M
National Cell and Tissue Culture Centre/BioResearch Ireland, Dublin City University, Ireland.
Cytotechnology. 1996;19(3):237-42. doi: 10.1007/BF00744218.
The correlation between cellular resistance to radiation and to chemotherapeutic drugs has been investigated in a number of solid tumour cell lines, and preliminary results indicate no direct relationship. The acquisition of a multidrug resistance (MDR) profile by adriamycin-selected variants of a human squamous lung carcinoma, an ovarian carcinoma, a cervical carcinoma and by a colchicine-selected variant of a Chinese hamster ovarian carcinoma resulted in alterations to their radiosensitivity. However, the degree of change in the radiosensitivity of the MDR cell lines could not be predicted from their level of resistance to adriamycin. Clonal populations derived from DLKP-A, an adriamycin-selected MDR variant of the human lung carcinoma cell line DLKP, exhibited individual radiosensitivity profiles, which did not correlate with their chemoresistance. Exposure of DLKP to consecutive increasing doses of radiation did not confer cross-resistance to chemotherapeutic drugs.
在多种实体瘤细胞系中研究了细胞对辐射和化疗药物的抗性之间的相关性,初步结果表明二者无直接关系。人肺鳞癌、卵巢癌、宫颈癌经阿霉素筛选的变体以及中国仓鼠卵巢癌经秋水仙碱筛选的变体获得多药耐药(MDR)特征后,其放射敏感性发生了改变。然而,MDR细胞系放射敏感性的变化程度无法根据其对阿霉素的耐药水平来预测。源自人肺癌细胞系DLKP经阿霉素筛选的MDR变体DLKP-A的克隆群体表现出个体放射敏感性特征,这与它们的化学抗性无关。将DLKP暴露于连续递增剂量的辐射下并未使其对化疗药物产生交叉抗性。